The Pharma Data

NOVEMBER 4, 2020

TSX: CTX) (OTC US: CRRTF) (“Crescita” or the “Company”), a growth-oriented, innovation-driven Canadian commercial dermatology company with in-house research & development (“R&D”) and manufacturing capabilities, today announced that it has entered into an exclusive agreement with Juyou-Biotechnology Co.

Licensing 40

Licensing Licensing Dermatology Production 40

Druggist

DECEMBER 9, 2020

Lotions: contain the least amount of oils and higher amounts of water with non-greasy consistency. Clobetasone (brand name: Eumovate cream). Clobetasone (brand name: Eumovate) is the second steroid cream on the list, which is available over the counter. Clobetasone has a narrow licensed use. Daktacort cream.

Pharmacy 97

Pharmacy Containment Sales Production 97

Druggist

MARCH 17, 2021

Lymecycline is usually prescribed as a generic drug – lymecycline 408mg capsules or occasionally as a branded medication called Tetralysal 300 mg capsules. Although licensed for acne, minocycline is rarely prescribed in the UK. Benzoyl peroxide is sold to treat acne from pharmacies as a branded product called Acnecide 5% gel.

Bacteria 59

Bacteria Dermatology Doctors Doctor 59

The Pharma Data

MAY 18, 2021

This business developed positively in the Europe/Middle East/Africa region and in Latin America, partly as a result of higher prices, whereas it shrank in North America, in part due to a license expiration. The performance remained ahead of competition with growth momentum in the Dermatology and Nutritionals categories, with business up by 6.6

Sales 40

Sales Production Marketing Containment 40

Delveinsight

AUGUST 13, 2020

It contains fluticasone furoate, an inhaled corticosteroid, umeclidinium, a long-acting muscarinic antagonist; and vilanterol, a long-acting beta2-adrenergic agonist, delivered in GSK’s Ellipta dry powder inhaler. Mometasone furoate is exclusively licensed to Novartis from a subsidiary of Merck & Co.,

Antibody 40

Antibody Medicine Trials Development 40

The Pharma Data

APRIL 26, 2021

COVID-19 negatively impacted demand, particularly: dermatology, ophthalmology, the breast cancer portfolio, Sandoz Retail and Anti-Infectives. billion declined, mainly due to the USD 650 million upfront payment to in-license tislelizumab from BeiGene. Adakveo sales reached USD 37 million. Free cash flow¹ of USD 1.6 Tafinlar + Mekinist.

Sales 40

Sales Medicine Production Manufacturing 40